Cardinal Health stock: Baird's USD 276.00 target leaves Cardinal Health stock 8.09 percent below it

Published on 10/16/2026 at 17:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-quarter results are due November 5, 2026. Cardinal Health stock costs EUR 227.05 on October 16, 2026, with USD 59.1 billion value.

Scheduled results and valuation

Baird's USD 276.00 target was above Cardinal Health's price on October 12, 2026.
Cardinal Health scheduled first-quarter fiscal 2027 results for November 5, 2026.
Cardinal Health stock costs EUR 227.05 at Lang & Schwarz on October 16, 2026 at 5:32 p.m. CEST.
Cardinal Health had a USD 59.1 billion market capitalization and a P/E ratio of 35.30 as of October 16, 2026.

Extreme Makroaufnahme weißer Kapseln in Silberfolie-Blisterpackung mit Bokeh-Hintergrund — Makro-Detailaufnahme weißer pharmazeutischer Kapseln in Blisterfolie – Cardinal Health Inc. ISIN US14149Y1082, Illustration mit AI erstellt.

Baird's USD 276.00 price target leaves Cardinal Health stock 8.09 percent below the target, according to Yahoo Finance on October 12, 2026. The target had risen from USD 274.00. Cardinal Health stock was trading at EUR 227.05 at Lang & Schwarz on October 16, 2026 at 5:32 p.m. CEST.

Target remains above the US quote

The comparison uses the US listing because Baird's target is denominated in USD. Cardinal Health traded at USD 255.34 on the NYSE on October 16, 2026 at 11:36 a.m. ET. Against that price, the USD 276.00 target stood 8.09 percent higher, keeping the analyst reference above the quoted US share price.

Annual high is within reach

The same-day US quote stood below Cardinal Health's USD 258.30 52-week high and above its USD 152.46 low. The distance to the high was 1.15 percent, while the market capitalization was USD 59.1 billion and the price-to-earnings ratio was 35.30 as of October 16, 2026. Trading volume reached 250,397 shares against an average of 1,798,935 shares.

November brings the next report

Cardinal Health is scheduled to release first-quarter fiscal 2027 results before the NYSE opens on November 5, 2026, and to webcast its discussion at 8:30 a.m. ET, according to Cardinal Health in its October 1, 2026 release. The reporting date gives the next clear calendar marker for the stock after the analyst target revision.

Healthcare distribution comparison

McKesson traded at USD 1,005.52 on October 16, 2026 at 11:36 a.m. ET, with a USD 117.2 billion market capitalization and a P/E ratio of 26.88. Cencora traded at USD 342.01 at 11:36 a.m. ET, with a USD 65.3 billion market capitalization and a P/E ratio of 25.42. Cardinal Health's USD 59.1 billion valuation was smaller than both peers, while its P/E ratio was higher.

Price stays the daily frame

For investors, the most relevant contrast is between the USD 276.00 analyst target and the current US quote at USD 255.34. The euro quotation provides the Germany-facing market view, while the NYSE price keeps the target comparison in one currency.

The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.